TS03 Inc Trust Units TSTIF

Steris

[StocksFTB]

Steris reported results yesterday beating street estimates on top and bottom line.  The stock moved up about 6% on the results.  The most interesting thing for Tso3 shareholders is that on the conference call Steris called out strength specifically in their vpro product family which is their competitive product to the vp4. They also referenced a growing backlog in their Healthcare products division.  

As expected short interest in ts03 continues to build as nearly 800k shares were shorted in the most recent 2 week period data.  A lot of trading is happening with the usual suspects anon and CIBC, but TD selling volume is also picking up again. 

I would expect continued volatility as shorts try and pressure the stock in the next few months and buy back their stock ahead of potential FDA news.